GlaxoSmithKline’s mission is to improve the quality of human life by enabling people to do more, feel better and live longer. This mission has led GSK to a world-leading position in developing new medicines, vaccines and consumer healthcare products that are used by millions of people around the world. GSK’s vision is for its value chain to be carbon neutral by 2050. GSK invests billions of dollars annually in research and development – including researching the World Health Organization’s three priority diseases: HIV/AIDS, tuberculosis and malaria. The U.S. commercial headquarters for GSK is located in RTP, while the corporate headquarters is in the United Kingdom.